Profarma Distribuidora de Produtos Farmacêuticos S.A., together with its subsidiaries, engages in the distribution and retail sale of pharmaceutical and hospital products in Brazil. The company operates through Distribution, and Retail segments. It provides branded medicines, generic drugs, and over-the-counter (OTC) medicines; personal hygiene, beauty, and cosmetic products, such as shampoos, conditioners, treatment creams and hair dyes, diapers and children's products, soaps , deodorants, oral care products, sunscreens, male products, cosmetics, makeup and skin products, and others; and hospital products, including injectable and infusion drugs for oncology, endocrinology, rheumatology, infectology, hematology, and other specialties. The company also offers vaccines for influenza, HPV, meningitis, hepatitis, chickenpox, dengue, and other diseases; special medicines intended for the treatment of rare and complex diseases; exclusive hygiene and beauty products, vitamins, and workshops products under the Nº21, GOnutri, and Bem Básico brands; and convenience products, including food products, pressure gauges, scales, and related products. In addition, it provides complementary services, such as promotional and logistical support, implementation of promotional campaigns, product recall, development of customized projects to offer laboratories solutions, and management of clinical procedures. As of December 31, 2019, the company operated eleven distribution centers located in the states of Alagoas, Bahia, Espírito Santo, Goiás, Minas Gerais, Paraíba, Paraná, Pernambuco, Rio Grande do Sul, Rio de Janeiro, and São Paulo, as well as approximately 196 stores in the states of Rio de Janeiro, Goiás, Tocantins, Mato Grosso, and Distrito Federal under the Drogarias Tamoio, Drogasmil, Farmalife, and Rede Rosário brands. The company was founded in 1961 and is headquartered in Rio de Janeiro, Brazil.
Profarma Distribuidora de Produtos Farmacêuticos Dividend Announcement
• Profarma Distribuidora de Produtos Farmacêuticos announced a quarterly dividend of R$0.24 per ordinary share which will be made payable on 2025-01-15. Ex dividend date: 2025-01-02
• Profarma Distribuidora de Produtos Farmacêuticos's trailing twelve-month (TTM) dividend yield is 8.33%
• Profarma Distribuidora de Produtos Farmacêuticos's payout ratio for the trailing twelve months (TTM) is 56.17%
Profarma Distribuidora de Produtos Farmacêuticos Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2025-01-02 | R$0.24 | quarterly | 2025-01-15 |
2024-12-02 | R$0.14 | quarterly | 2024-12-12 |
2024-11-12 | R$0.14 | quarterly | 2024-11-26 |
2024-01-02 | R$0.27 | quarterly | 2024-01-10 |
2023-12-01 | R$0.12 | quarterly | 2023-12-12 |
2022-12-21 | R$0.17 | quarterly | 2023-01-13 |
2021-11-22 | R$0.27 | quarterly | 2021-12-01 |
2014-05-02 | R$0.14 | quarterly | |
2013-04-30 | R$0.20 | quarterly | |
2012-04-24 | R$0.14 | quarterly | |
2011-05-02 | R$0.13 | quarterly | |
2010-05-03 | R$0.26 | quarterly |
Profarma Distribuidora de Produtos Farmacêuticos Dividend per year
Profarma Distribuidora de Produtos Farmacêuticos Dividend growth
Profarma Distribuidora de Produtos Farmacêuticos Dividend Yield
Profarma Distribuidora de Produtos Farmacêuticos current trailing twelve-month (TTM) dividend yield is 8.33%. Interested in purchasing Profarma Distribuidora de Produtos Farmacêuticos stock? Use our calculator to estimate your expected dividend yield:
Profarma Distribuidora de Produtos Farmacêuticos Financial Ratios
Profarma Distribuidora de Produtos Farmacêuticos Dividend FAQ
Other factors to consider when evaluating Profarma Distribuidora de Produtos Farmacêuticos as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Profarma Distribuidora de Produtos Farmacêuticos stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Profarma Distribuidora de Produtos Farmacêuticos's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Profarma Distribuidora de Produtos Farmacêuticos publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Profarma Distribuidora de Produtos Farmacêuticos distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Profarma Distribuidora de Produtos Farmacêuticos are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Profarma Distribuidora de Produtos Farmacêuticos sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Profarma Distribuidora de Produtos Farmacêuticos distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Profarma Distribuidora de Produtos Farmacêuticos declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Profarma Distribuidora de Produtos Farmacêuticos's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Profarma Distribuidora de Produtos Farmacêuticos's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.